PRR11 and non-small cell lung carcinoma: Preliminary studies on treating NSCLC patients demonstrated that lncRNA DLX6-AS1 knockdown inhibited cell proliferation, migration, invasion and initiated apoptosis targeting PRR11 in NSCLCs [37].